The one you can actually beat

Gout is the only arthritis you can cure, and most people quit right before it works.

The crystals melting your joints dissolve once uric acid stays below 6.0 mg/dL long enough. Hold the line and the disease effectively disappears. Yet fewer than half of patients stay on the one medicine that does it, and that gap, not the biology, is why people still suffer.

◆ Compiled from ACR 2020 · EULAR · 2024–2026 trials ◆ Every claim sourced ◆ Read time ≈ 8 min

6.8

mg/dL: the saturation point. Below it, monosodium urate crystals stop forming and start dissolving.

36.8%

of gout patients still take their urate drug after year one: the worst adherence of any chronic disease studied.

>90%

of patients reach a flare-free "cure" when treated to target with steady follow-up.

~110k

patients in a 2026 study: reaching sub-6 urate meant fewer heart attacks and longer survival.

What's actually happening inside the joint

Drag the timeline ↔

Bone & cartilage Urate crystals Tophus (the lump they build)

Phase one · years

How the crystals build up

Uric acid sits above 6.8 mg/dL, and crystals start seeding on the cartilage.

● Flare

Serum urate

9.2

Crystal load

Time elapsed

Year 0

Year 0Year 3Year 7+

Phase two · months

How the crystals clear

Treatment drives urate below 6.0. Under the saturation point, crystals can't hold.

✓ Clearing

Serum urate

9.2

Deposit left

100%

Time elapsed

Month 0

Month 0Month 6Month 12+

What the evidence actually says

Tap any story to open it

The core idea

“6.0” is the entire game: a target, not a diet plan

Gout isn't a string of bad-luck attacks. It's one measurable number. Get serum uric acid reliably under 6.0 mg/dL and keep it there, and the crystals that cause everything slowly dissolve.

Read the science ›

Crystals form above urate's saturation point of about 6.8 mg/dL and dissolve below it, so guidelines target under 6.0 for everyone, and under 5.0 when there are visible lumps (tophi), because lower urate dissolves deposits faster. At 6.0 a deposit shrinks ~8% a month; at 4.0, ~21% a month.

This is "treat to target": start low, re-check the blood number every few weeks, and raise the dose until you hit it. In disciplined treat-to-target programs, over 90% of patients become flare-free. The drugs are not the bottleneck. Reaching and holding the number is.

What it means for you

Ask for the actual serum-urate number at every visit. "On allopurinol" isn't the goal. "Under 6.0, confirmed by blood test" is.

ACR 2020 Gout Guideline (PMC10563586); Perez-Ruiz, Rheumatology 2009; DECT dissolution study, Mod Rheumatol 2020.

Why it fails

People stop the moment they feel fine

The drug works silently, so it feels like it's doing nothing. That misread is the #1 reason gout wins.

Read the science ›

Pooled adherence to urate-lowering therapy is about 47%, and in head-to-head data it's the worst of seven chronic conditions (gout 36.8% vs hypertension 72% in year one). In one country cohort, just 3.2% were still on allopurinol at a year. More than half of patients quit.

Why: gout is silent between attacks, the pill is preventive and lifelong, and the benefit is invisible. People treat it like a sprained ankle (pain gone, problem solved) while the crystals quietly rebuild.

What it means for you

"Feeling better" is the trap, not the finish line. The medicine is working because you feel nothing. Don't stop without a urate test and your doctor.

Scheepers et al., Semin Arthritis Rheum 2018; adherence review PMC5939914; CreakyJoints patient survey.

The trap

It gets worse before it gets better, by design

Starting allopurinol often triggers flares. Patients think the drug failed and quit at exactly the wrong moment.

Read the science ›

Lowering urate pulls existing crystals out of tissue, and your immune system attacks them on the way out, so the first weeks-to-months can bring more flares. It's a sign the deposits are mobilizing, not a sign of failure.

That's why guidelines say to co-prescribe low-dose colchicine (or an NSAID/steroid) for the first 3–6 months as a shield. Knowing this is coming is itself the intervention that stops people quitting in week three.

What it means for you

Expect a bumpy start and ask for flare prophylaxis up front. "Worse before better" is the treatment working. Push through it, don't bail.

ACR 2020 Gout Guideline; EULAR 2017 (Richette et al.); WebMD patient reviews.

First-line drug

Allopurinol: start low, climb until the number drops

Cheap, decades-proven, and first choice for almost everyone, including people with kidney disease. The mistake is parking it at one dose forever.

Read the science ›

Start at 100 mg/day or less (lower in kidney disease), then raise it every 2–5 weeks, guided by blood tests, until urate is under 6. The old habit of capping at 300 mg leaves half of patients above target; the dose can go up to 800 mg if needed.

One safety step: people of Southeast-Asian (Han Chinese, Korean, Thai) or African-American descent should get an HLA-B*5801 gene test first; that allele raises the risk of a rare, serious allopurinol rash. If allopurinol can't be tolerated, febuxostat is the main alternative (carries a debated cardiovascular caution).

What it means for you

If you've been on the same allopurinol dose for years and never re-checked your urate, you may be "treated" but not at target. Ask to titrate.

ACR 2020 Gout Guideline (PMC10563586); CARES NEJM 2018 & FAST Lancet 2020 (febuxostat); Healio ULT guidance.

“Studies show 50% of patients on standard allopurinol doses never reach the target. The dose must be chased to a number, not set and forgotten.”

Arthritis Foundation clinical Q&A · “Why is my gout not getting better?”

Acute attack

The flare playbook patients swear by

When an attack hits, speed and the right drug matter more than anything. Here's the repeatable consensus.

Read the playbook ›

1. Hit it at the first twinge. Low-dose colchicine (1.2 mg, then 0.6 mg an hour later) or an NSAID like naproxen, within the first 24 hours, not "wait and see."

2. Ice and elevate. Wrapped ice 20–30 min, joint up. 3. NSAIDs, never aspirin: low-dose aspirin actually raises urate. 4. If you're already on allopurinol, keep taking it through the flare; stopping prolongs it. 5. Steroids (oral or injected) are the fallback when NSAIDs/colchicine aren't safe.

6. Not easing in ~48 hours? Call a doctor, and rule out a septic (infected) joint, which mimics gout and is an emergency.

What it means for you

Keep a flare kit and a plan ready before the next attack. The patients who suffer least are the ones who treat within the hour, not the day.

ACR 2020 Gout Guideline; UpToDate "Gout: treatment of flares"; r/gout & WebMD patient consensus.

The bonus

Lower urate now protects your heart, not just your toe

A 2026 study reframed the whole goal: hitting target isn't only about joints: it's cardiovascular prevention.

Read the science ›

In a ~110,000-patient study (JAMA Internal Medicine, 2026) linking national registries, patients who reached urate under 6 had higher 5-year survival, fewer major cardiovascular events, and fewer flares than those left "fire-and-forget." The benefit was bigger below 5 and in higher-risk hearts.

It fits a growing picture: high urate travels with kidney disease, high blood pressure and heart attacks. Dissolving the crystals may be buying you more than pain-free joints.

What it means for you

Treating gout to target is now a heart-and-kidney decision too, one more reason not to coast above 6.

JAMA Intern Med 2026 (PubMed 41587055); EULAR 2025 OP0005.

The twist

Weight-loss shots: helpful long-term, bumpy at first

GLP-1 drugs like semaglutide and tirzepatide lower urate over time, but the headlines arguing they "cause gout" aren't wrong either.

Read the science ›

Over months, tirzepatide dropped urate ~0.95 mg/dL (mostly via weight loss), and GLP-1 users had ~18% lower long-term gout risk in a 217,000-patient cohort. Net, they help.

But rapid early weight loss can transiently spike urate and trigger flares in the first months: the same mobilization effect as starting any urate drug. "GLP-1s cause gout" captures the early bump; it misses the long-run benefit. Both are true at different timescales.

What it means for you

If you start a GLP-1 and have gout, expect possible early flares, keep urate monitored, and don't panic-quit; the trajectory bends the right way.

SURMOUNT-1 post hoc (PubMed 41198460, 2026); TriNetX cohort, ARD 2025; AACE case series 2026.

The diet myth

Diet matters, but it can't out-eat your genes

A perfect purine diet lowers urate by at most ~1 mg/dL. Useful, but rarely enough alone to dissolve established gout, and believing otherwise delays real treatment.

Read the science ›

Genetics drives ~24% of your urate level; diet, under 0.3%. So the strict-diet-as-cure plan tends to end in "nothing works," when really the person was never on adequate medication.

What does help at the margins: cutting beer and spirits, cutting sugary soda and fructose, losing weight, and staying hydrated: the changes patients most consistently credit with fewer flares. The DASH diet shaved ~0.55 mg/dL in a trial. Tart cherry has modest evidence for fewer flares (not lower urate), an adjunct, never a swap for medication. Vitamin C, once hyped, has been walked back.

What it means for you

Treat diet as a helper, not the cure. Cut alcohol and sugary drinks for real gains, but keep the urate drug doing the heavy lifting.

CreakyJoints (genetics ~24% vs diet <0.3%); DASH/DIGO pilot, Nutrients 2021; cherry RCTs 2011/2012; 2024 reviews on vitamin C.

Avoid these

Folk “cures” that do nothing, or harm

The internet is full of urate hacks. A few are useless; a couple are genuinely risky for the exact people who get gout.

Read the warnings ›

Baking soda by mouth: passed around as a uric-acid "cure," it's a heavy sodium load that can spike blood pressure and strain kidneys, dangerous for the hypertensive/kidney patients who disproportionately have gout.

Apple cider vinegar: no evidence it lowers urate. Aspirin for the pain: wrong drug; low-dose aspirin raises urate. Sugary "cherry cocktail": the fructose makes gout worse; only unsweetened tart cherry as an adjunct. And the most harmful belief of all: that a perfect diet alone will cure it.

What it means for you

Skip the kitchen-cabinet cures. None replace getting urate under 6, and baking soda can actively hurt.

Gout Education Society; Medical News Today / WebMD folk-remedy reviews; patient-safety literature.

The human part

The “rich man’s disease” myth costs people years

Gout's punchline reputation isn't just unfair; it actively delays treatment and feeds the shame that makes people hide from care.

Read the science ›

Gout is overwhelmingly genetic and hits every income bracket, yet 64% of patients blame themselves, and many are told they're "too young for gout"; one advocate went 16 years before being taken seriously, ending up with permanent joint and kidney damage. The stigma sends people home with a diet pamphlet instead of a blood test and a prescription.

The repeated turning point in patient stories is hearing that it's a transporter problem you were born with, not a character flaw. That single reframe is what lets people stop hiding and actually stay on treatment.

What it means for you

If a clinician dismisses you, push for the urate test and a rheumatology referral. You didn't eat your way into this, and you can treat it.

CreakyJoints survey (64% self-blame); Gout Education Society & Gout Support Group of America patient stories; internalized-stigma study (PMC).

On the horizon

2024–2026 pipeline

Today's drugs already cure gout when used to target. The frontier is dissolving crystals faster, in pill form, for the hardest cases, plus a new understanding that the gut, not just the kidney, dumps urate.

Now standard

Pegloticase + methotrexate

refractory gout · MIRROR trial

Adding methotrexate to the IV uricase drug blunts the antibodies that used to make it fail; it now clears even severe tophi durably.

Approved (Asia) · US Ph 3

Dotinurad

URAT1 blocker · oral

A selective uricosuric beating febuxostat in a 451-patient trial (73.6% vs 38.1% to target). US Phase 3 underway; readout ~2027.

Phase 3 · readout late 2026

AR882 (pozdeutinurad)

oral URAT1 · tophaceous gout

Striking for a pill: 43–57% of refractory patients had complete resolution of a target tophus, territory once reserved for IV drugs.

BLA filed

SEL-212

monthly uricase + tolerance tech

A pegloticase successor that uses an immune-tolerance nanoparticle to stop anti-drug antibodies, and doses once a month, not twice.

Phase 3 · EURELIA

Tigulixostat

new production blocker

A fresh xanthine-oxidase inhibitor that outperformed febuxostat in Phase 2 (81% vs 9% to a tight target). Phase 3 reading out.

Already on shelves

SGLT2 inhibitors

repurposed · diabetes/heart/kidney

Drugs like empagliflozin lower urate and cut gout risk as a side benefit: a genuine two-for-one for patients with diabetes or heart failure.

Emerging science

The gut–urate axis

ABCG2 · microbiome

Up to a third of urate leaves through the intestine via the ABCG2 transporter. Butyrate-producing microbes may boost it: a whole new lever.

Mapped 2024

351 genetic loci

1,029,323-person GWAS

The largest-ever urate gene map confirms the disease lives in the transporters: the blueprint for every next-generation drug above.

If you take one thing from this: chase the number, and don't stop.

Know your urate

Ask for the serum uric acid number, not just "is it gout."

Treat to under 6

Start urate-lowering therapy and titrate the dose by blood test.

Shield the start

Use colchicine/NSAID cover for 3–6 months through early flares.

Stay on it

It's lifelong and silent. Re-test, don't quit when you feel fine.

Cut the real triggers

Less beer, spirits and sugary soda. Hydrate. Diet helps at the edges.

r/gout community ↗ Gout Education Society ↗ Arthritis Foundation ↗ CreakyJoints ↗